Elizabeth G Nabel Medtronic PLC (MDT) insider trading activity

Elizabeth G Nabel is Director of Medtronic plc. Currently has a direct ownership of 15,674 shares of MDT, which is worth approximately $1.35 Million. The most recent transaction as insider was on May 01, 2024, when has been sold 192 shares (Ordinary Shares) at a price of $80.89 per share, resulting in proceeds of $15,530. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.7K

0% 3M change

14.95% 12M change

Total Value Held $1.35 Million

ELIZABETH G NABEL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 01 2024	SELL Payment of exercise price or tax liability	$15,530 $80.89 p/Share	192 Reduced 1.21%	15,674 Ordinary Shares
Apr 29 2024	BUY Grant, award, or other acquisition	$175,061 $80.86 p/Share	2,165 Added 12.01%	15,866 Ordinary Shares
May 02 2023	SELL Payment of exercise price or tax liability	$15,248 $90.23 p/Share	169 Reduced 1.22%	13,635 Ordinary Shares
May 01 2023	BUY Grant, award, or other acquisition	$175,012 $90.68 p/Share	1,930 Added 12.27%	13,804 Ordinary Shares
May 03 2022	SELL Payment of exercise price or tax liability	$27,015 $103.11 p/Share	262 Reduced 2.17%	11,818 Ordinary Shares
May 02 2022	BUY Grant, award, or other acquisition	-	1,697 Added 12.32%	12,080 Ordinary Shares
May 03 2021	BUY Grant, award, or other acquisition	-	1,334 Added 11.41%	10,353 Ordinary Shares
Apr 27 2021	SELL Payment of exercise price or tax liability	$55,367 $129.97 p/Share	426 Reduced 4.51%	9,019 Ordinary Shares
Apr 29 2020	SELL Payment of exercise price or tax liability	$38,962 $99.14 p/Share	393 Reduced 4.01%	9,408 Ordinary Shares
Apr 27 2020	BUY Grant, award, or other acquisition	-	1,737 Added 15.05%	9,801 Ordinary Shares
Apr 30 2019	SELL Payment of exercise price or tax liability	$38,099 $88.81 p/Share	429 Reduced 5.08%	8,023 Ordinary Shares
Apr 29 2019	BUY Grant, award, or other acquisition	-	2,002 Added 19.15%	8,452 Ordinary Shares
May 01 2018	SELL Payment of exercise price or tax liability	$49,902 $81.01 p/Share	616 Reduced 8.78%	6,400 Ordinary Shares
Apr 30 2018	BUY Grant, award, or other acquisition	-	2,184 Added 23.74%	7,016 Ordinary Shares
May 02 2017	SELL Payment of exercise price or tax liability	$55,088 $84.75 p/Share	650 Reduced 11.96%	4,784 Ordinary Shares
May 01 2017	BUY Grant, award, or other acquisition	-	2,090 Added 27.78%	5,434 Ordinary Shares
May 02 2016	BUY Grant, award, or other acquisition	-	2,206 Added 40.09%	3,296 Ordinary Shares
Apr 27 2016	SELL Payment of exercise price or tax liability	$13,189 $79.45 p/Share	166 Reduced 13.22%	1,090 Ordinary Shares
Apr 27 2015	BUY Grant, award, or other acquisition	-	1,230 Added 50.0%	1,230 Ordinary Shares

Also insider at

MRNA

Moderna, Inc. Healthcare

Director

ACCD

Accolade, Inc. Healthcare

Director

LYEL

Lyell Immunopharma, Inc. Healthcare

EGN